SuperworthHumana EPS HUM
Diluted earnings per share by quarter and over the last twelve months, from 2008.
- Last 12 months, to Jun 30, 2026
- $10.57
- Latest quarter, Q2 FY26
- $5.73
- +27% on a year earlier
- Fiscal year 2025
- $9.82
- −1% on the year before
Humana's earnings per share was $10.57 over the twelve months to Jun 30, 2026, down 19% on a year earlier.
In its latest quarter, Q2 FY26, it was $5.73, up 27% on the same quarter a year before.
Over the five fiscal years to FY2025 it shrank 17% a year on average.
Earnings per share over time
Fiscal year by fiscal year
| Fiscal year | EPS | Change |
|---|---|---|
| FY2025 | $9.82 | −1% |
| FY2024 | $9.96 | −50% |
| FY2023 | $19.82 | −10% |
| FY2022 | $22.04 | −3% |
| FY2021 | $22.67 | −10% |
| FY2020 | $25.29 | +26% |
| FY2019 | $20.08 | +65% |
| FY2018 | $12.15 | −27% |
| FY2017 | $16.68 | +313% |
| FY2016 | $4.04 | −52% |
| FY2015 | $8.43 | +15% |
| FY2014 | $7.33 | −5% |
| FY2013 | $7.70 | +3% |
| FY2012 | $7.46 | −12% |
| FY2011 | $8.44 | +30% |
Each fiscal year is the twelve months to its fourth quarter.
Quarter by quarter
| Quarter | Ended | EPS | On a year earlier | Last 12 months |
|---|---|---|---|---|
| Q2 FY26 | $5.73 | +27% | $10.57 | |
| Q1 FY26 | $9.83 | −5% | $9.35 | |
| Q4 FY25 | −$6.61 | n/a | $9.82 | |
| Q3 FY25 | $1.62 | −59% | $10.68 | |
| Q2 FY25 | $4.51 | −20% | $13.04 | |
| Q1 FY25 | $10.30 | +69% | $14.15 | |
| Q4 FY24 | −$5.75 | n/a | $9.96 | |
| Q3 FY24 | $3.98 | −41% | $11.29 | |
| Q2 FY24 | $5.62 | −27% | $14.02 | |
| Q1 FY24 | $6.11 | −38% | $16.06 | |
| Q4 FY23 | −$4.42 | n/a | $19.82 | |
| Q3 FY23 | $6.71 | −29% | $24.12 |
Against its peers
Companies in Medical - Healthcare Plans nearest Humana's size, closest first, today.
| Company | EPS, 12 months | Growth |
|---|---|---|
| HUMHumana | $10.57 | −19% a year |
| CNCCentene | −$10.44 | −358% a year |
| CICigna | $24.17 | +32% a year |
| ELVElevance Health | $22.50 | −4% a year |
| CVSCVS Health | $3.79 | +6% a year |
| OSCROscar Health | $1.39 | |
| UNHUnitedHealth | $17.51 | −9% a year |
| Peer median | $10.65 |
What the EPS figure tells you
Net income divided by diluted shares. The denominator of PE.
One-off charges and gains swing it. The TTM view smooths a single odd quarter.
More on Humana
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.